EIKN logo

Eikon Therapeutics, Inc. Common Stock

EIKN
Healthcare|Biotechnology|US
$5.90
+0.06 (+1.03%)
Tangible Book / Share
$8.62
Cash / Share
$9.82
Next Earnings Report
Nov 12, 2026
EPS est. -$1.74
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Feb 5, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Eikon Therapeutics to Participate in Multiple Investor Conferences in November
Nov 2, 2026 · GlobeNewsWire
Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress
Oct 26, 2026 · GlobeNewsWire
Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress
Oct 23, 2026 · GlobeNewsWire
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
Oct 18, 2026 · GlobeNewsWire
Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
Oct 15, 2026 · GlobeNewsWire
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
Sep 3, 2026 · GlobeNewsWire
Eikon Therapeutics to Participate in Investor Conferences in September 2026
Aug 26, 2026 · GlobeNewsWire
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
Aug 18, 2026 · GlobeNewsWire
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Aug 13, 2026 · GlobeNewsWire
Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board
Aug 10, 2026 · GlobeNewsWire

SEC Filings (36)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 26, 20268-KMaterial eventDocumentIndex
Oct 23, 20268-KMaterial eventDocumentIndex
Oct 7, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 2, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jun 10, 20268-KMaterial eventDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 11, 202610-QQuarterly reportDocumentIndex
May 11, 20268-KMaterial eventDocumentIndex
May 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Feb 18, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 12, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Feb 11, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 6, 2026S-8Employee stock planDocumentIndex
Feb 6, 20268-KMaterial eventDocumentIndex
Feb 5, 2026424B4Offering prospectusDocumentIndex
Feb 4, 2026S-1MEFIPO / offering registrationDocumentIndex
Feb 4, 2026CERTDocumentIndex
Jan 30, 2026EFFECTDocumentIndex
Jan 28, 20268-A12BDocumentIndex
Jan 28, 2026S-1/AIPO / offering registrationDocumentIndex
Jan 9, 2026S-1IPO / offering registrationDocumentIndex
Dec 12, 2025DRS/ADocumentIndex
Sep 26, 2025DRS/ADocumentIndex
Jul 1, 2025DRS/ADocumentIndex
May 9, 2025DRSDocumentIndex
Feb 28, 2025DDocumentIndex